Skip to main content
OpenTrials

Clinical trial condition

Thrombocytopenia

Explore clinical trials studying Thrombocytopenia. Study availability and eligibility vary by location and protocol.

403 public trials 115 recruiting studies
Refine in advanced search Browse all conditions

Thrombocytopenia trial results

Active, Not Recruiting

A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies

NCT05885555

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Med Center Boston, Massachusetts, United States
  • Novartis Investigative Site CABA, Argentina
  • Novartis Investigative Site Garran, Australian Capital Territory, Australia
View all 24 locations
View Trial Details
Active, Not Recruiting

A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

NCT04683003

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations
  • Childrens Healthcare of Atlanta Atlanta, Georgia, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Mid Ohio Heart Clinic Inc Dublin, Ohio, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

NCT04958265

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +14 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • University of Nebraska Omaha, Nebraska, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • UZ Gent Ghent, Belgium
View all 20 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

NCT04562766

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Southern California_Investigational Site Number 84024 Los Angeles, California, United States
  • UCSF Benioff Children's Hospital San Francisco_Investigational Site Number 84020 San Francisco, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center_Investigational Site Number 84037 Torrance, California, United States
  • The Oncology Institute of Hope and Innovation_Investigational Site Number 84031 Whittier, California, United States
View all 155 locations
View Trial Details
Active, Not Recruiting

Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura

NCT05046717

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Centro Hospitalar e Universitario de Coimbra Coimbra, Coimbra District, Portugal
  • Complejo Hospitalario Universitario A Coruña A Coruña, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Hospital Clínico San Carlos Madrid, Spain
View Trial Details
Active, Not Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

NCT04812925

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010116 Bentonville, Arkansas, United States
  • Investigator site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010062 Fort Wayne, Indiana, United States
  • Investigator site US0010042 Iowa City, Iowa, United States
View all 83 locations
View Trial Details

Related conditions